当前蛋白身份:P0AEG4 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
2B3S structure of the DSBA mutant (P31G-C33A) 提交 2005-09-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa) 片段:enzyme DsbA
突变:P31G , C33A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;PEG 400, Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 7.50
分辨率 1.96 Å R-free 0.257
2B3S structure of the DSBA mutant (P31G-C33A) 提交 2005-09-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa) 片段:enzyme DsbA
突变:P31G , C33A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;PEG 400, Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 7.50
分辨率 1.96 Å R-free 0.257
2B3S structure of the DSBA mutant (P31G-C33A) 提交 2005-09-21 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 20–208(189 aa) 片段:enzyme DsbA
链 B 20–208(189 aa) 片段:enzyme DsbA
突变:P31G , C33A 突变:P31G , C33A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;PEG 400, Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 7.50
分辨率 1.96 Å R-free 0.257
2B6M Structure of the DsbA mutant (P31A-C33A) 提交 2005-10-03 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
突变:P31A, C33A PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.2;293 K;PEG 3350, ammonium phosphate, pH 8.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.65 Å R-free 0.258
2B6M Structure of the DsbA mutant (P31A-C33A) 提交 2005-10-03 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
突变:P31A, C33A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.2;293 K;PEG 3350, ammonium phosphate, pH 8.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.65 Å R-free 0.258
2HI7 Crystal structure of DsbA-DsbB-ubiquinone complex 提交 2006-06-29 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 20–208(189 aa)
突变:C33A ZN ZINC ION × 1 UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;JeffamimeED2001, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 3.70 Å R-free 0.362
2HI7 Crystal structure of DsbA-DsbB-ubiquinone complex 提交 2006-06-29 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 20–208(189 aa)
突变:C33A ZN ZINC ION × 2 UQ1 UBIQUINONE-1 × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;JeffamimeED2001, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 3.70 Å R-free 0.362
2LEG Membrane protein complex DsbB-DsbA structure by joint calculations with solid-state NMR and X-ray experimental data 提交 2011-06-15 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 20–208(189 aa)
突变:C33A ZN ZINC ION × 1 UQ1 UBIQUINONE-1 × 1 SOLID-STATE NMR
NMR测量条件 pH 7;270 K;压力 ambient
NMR测量条件 pH 7.8;261 K;压力 ambient
NMR样品组成 15 mg [U-100% 13C; U-100% 15N] DsbA, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 10 mg [2-13C-glycerol; U-15N] DsbA, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 10 mg [1,3-13C-glycerol; U-15N] DsbA, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 7 mg [U-100% 13C; U-100% 15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 5 mg [2-13C-glycerol; U-15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 4 mg [1,3-13C-glycerol; U-15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
分辨率未提供
2NDO Structure of EcDsbA-sulfonamide1 complex 提交 2016-08-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 SFQ 2-{[(4-iodophenyl)sulfonyl]amino}benzoic acid × 1 SOLUTION NMR
NMR测量条件 pH 6.8;300 K;离子强度(mmCIF原始值)50;压力 ambient
NMR测量条件 pH 6.8;300 K;离子强度(mmCIF原始值)50;压力 ambient
NMR样品组成 0.35 mM Isotopomer sample Oxidised EcDsbA, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 0.4 mM [U-99% 13C; U-99% 15N] Oxidised EcDsbA, 1.5 mM Sulfonamide1, 100% D2O | 100% D2O
分辨率未提供
2ZUP Updated crystal structure of DsbB-DsbA complex from E. coli 提交 2008-10-28 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 20–208(189 aa)
突变:C33A ZN ZINC ION × 1 UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;pH 7;293 K;23% Jeffamine ED2001, 80mM HEPES, 14.4% glycerol, 2mM ZnCl2, pH 7.0, EVAPORATION, temperature 293K
分辨率 3.70 Å R-free 0.334
3E9J Structure of the charge-transfer intermediate of the transmembrane redox catalyst DsbB 提交 2008-08-22 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 20–208(189 aa)
突变:C33A UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.9;277 K;23% PEG550 MME, 50 mM Tris pH 8.9, 1.0 M ammonium formate, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 3.70 Å R-free 0.379
3E9J Structure of the charge-transfer intermediate of the transmembrane redox catalyst DsbB 提交 2008-08-22 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 20–208(189 aa)
突变:C33A UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.9;277 K;23% PEG550 MME, 50 mM Tris pH 8.9, 1.0 M ammonium formate, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 3.70 Å R-free 0.379
4TKY The complex structure of E. coli DsbA bound to a peptide at the DsbA/DsbB interface 提交 2014-05-28 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 20–208(189 aa) 片段:UNP residues 20-208
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;Ammonium sulfate, BIS-TRIS, Pentaerythritol ethoxylate
分辨率 2.50 Å R-free 0.237
4TKY The complex structure of E. coli DsbA bound to a peptide at the DsbA/DsbB interface 提交 2014-05-28 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 20–208(189 aa) 片段:UNP residues 20-208
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;Ammonium sulfate, BIS-TRIS, Pentaerythritol ethoxylate
分辨率 2.50 Å R-free 0.237
4TKY The complex structure of E. coli DsbA bound to a peptide at the DsbA/DsbB interface 提交 2014-05-28 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 20–208(189 aa) 片段:UNP residues 20-208
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;Ammonium sulfate, BIS-TRIS, Pentaerythritol ethoxylate
分辨率 2.50 Å R-free 0.237
4TKY The complex structure of E. coli DsbA bound to a peptide at the DsbA/DsbB interface 提交 2014-05-28 Assembly 4 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 20–208(189 aa) 片段:UNP residues 20-208
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;Ammonium sulfate, BIS-TRIS, Pentaerythritol ethoxylate
分辨率 2.50 Å R-free 0.237
4ZIJ Crystal structure of E.Coli DsbA in complex with 2-(4-iodophenylsulfonamido) benzoic acid 提交 2015-04-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–207(188 aa) 片段:UNP residues 20-207
未记录 SFQ 2-{[(4-iodophenyl)sulfonyl]amino}benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;100-200 mM KBr, 22-27% PEG 2000 MME
分辨率 1.78 Å R-free 0.217
4ZIJ Crystal structure of E.Coli DsbA in complex with 2-(4-iodophenylsulfonamido) benzoic acid 提交 2015-04-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–207(188 aa) 片段:UNP residues 20-207
未记录 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;100-200 mM KBr, 22-27% PEG 2000 MME
分辨率 1.78 Å R-free 0.217
6BQX Crystal structure of Escherichia coli DsbA in complex with N-methyl-1-(4-phenoxyphenyl)methanamine 提交 2017-11-29 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 9AG N-methyl-1-(4-phenoxyphenyl)methanamine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.244
6BQX Crystal structure of Escherichia coli DsbA in complex with N-methyl-1-(4-phenoxyphenyl)methanamine 提交 2017-11-29 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.244
6BR4 Crystal structure of Escherichia coli DsbA in complex with {N}-methyl-1-(3-thiophen-2-ylphenyl)methanamine 提交 2017-11-29 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 60L ~{N}-methyl-1-(3-thiophen-2-ylphenyl)methanamine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.215
6BR4 Crystal structure of Escherichia coli DsbA in complex with {N}-methyl-1-(3-thiophen-2-ylphenyl)methanamine 提交 2017-11-29 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.215
6PBI Crystal Structure of EcDsbA in a complex with purified morpholine 8 提交 2019-06-13 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 O6Y 2-methyl-4-{4-[2-(morpholin-4-yl)-2-oxoethyl]phenoxy}benzonitrile × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;25-35 % PEG MME 2000, 100-300 mM KBr
分辨率 1.90 Å R-free 0.228
6PBI Crystal Structure of EcDsbA in a complex with purified morpholine 8 提交 2019-06-13 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;25-35 % PEG MME 2000, 100-300 mM KBr
分辨率 1.90 Å R-free 0.228
6PC9 Crystal Structure of EcDsbA in a complex with purified methylpiperazinone 6 提交 2019-06-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 O7P 2-methyl-4-{4-[2-(4-methyl-3-oxopiperazin-1-yl)-2-oxoethyl]phenoxy}benzonitrile × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;25-35 % PEG MME 2000, 100-300 mM KBr
分辨率 2.30 Å R-free 0.244
6PC9 Crystal Structure of EcDsbA in a complex with purified methylpiperazinone 6 提交 2019-06-17 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;25-35 % PEG MME 2000, 100-300 mM KBr
分辨率 2.30 Å R-free 0.244
6PD7 Crystal Structure of EcDsbA in a complex with purified morpholine carboxylic acid 7 提交 2019-06-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 OAJ (3R)-4-{[4-(4-cyano-3-methylphenoxy)phenyl]acetyl}morpholine-3-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;25-35 % PEG MME 2000, 100-300 mM KBr
分辨率 1.92 Å R-free 0.231
6PD7 Crystal Structure of EcDsbA in a complex with purified morpholine carboxylic acid 7 提交 2019-06-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;25-35 % PEG MME 2000, 100-300 mM KBr
分辨率 1.92 Å R-free 0.231
6PDH Crystal Structure of EcDsbA in a complex with purified pyrazole 9 提交 2019-06-19 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 OAV 2-[4-(4-cyano-3-methylphenoxy)phenyl]-N-ethyl-N-[2-(1H-pyrazol-1-yl)ethyl]acetamide × 1 PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;25-35 % PEG MME 2000, 100-300 mM KBr
分辨率 1.96 Å R-free 0.245
6PDH Crystal Structure of EcDsbA in a complex with purified pyrazole 9 提交 2019-06-19 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;25-35 % PEG MME 2000, 100-300 mM KBr
分辨率 1.96 Å R-free 0.245
6PG1 Crystal Structure of EcDsbA in a complex with unpurified reaction product F1 (methylpiperazinone 6) 提交 2019-06-23 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 O7P 2-methyl-4-{4-[2-(4-methyl-3-oxopiperazin-1-yl)-2-oxoethyl]phenoxy}benzonitrile × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 2.01 Å R-free 0.264
6PG1 Crystal Structure of EcDsbA in a complex with unpurified reaction product F1 (methylpiperazinone 6) 提交 2019-06-23 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 2.01 Å R-free 0.264
6PG2 Crystal Structure of EcDsbA in a complex with unpurified reaction product H5 (morpholine 8) 提交 2019-06-23 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 O6Y 2-methyl-4-{4-[2-(morpholin-4-yl)-2-oxoethyl]phenoxy}benzonitrile × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.91 Å R-free 0.223
6PG2 Crystal Structure of EcDsbA in a complex with unpurified reaction product H5 (morpholine 8) 提交 2019-06-23 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.91 Å R-free 0.223
6PGJ Crystal Structure of EcDsbA in a complex with unpurified reaction product A5 (Morpholine carboxylic acid 7) 提交 2019-06-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 OMJ (3S)-4-{[4-(4-cyano-3-methylphenoxy)phenyl]acetyl}morpholine-3-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.90 Å R-free 0.226
6PGJ Crystal Structure of EcDsbA in a complex with unpurified reaction product A5 (Morpholine carboxylic acid 7) 提交 2019-06-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 2 OAJ (3R)-4-{[4-(4-cyano-3-methylphenoxy)phenyl]acetyl}morpholine-3-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.90 Å R-free 0.226
6PIQ Crystal Structure of EcDsbA in a complex with unpurified reaction product G6 (pyrazole 9) 提交 2019-06-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 OAV 2-[4-(4-cyano-3-methylphenoxy)phenyl]-N-ethyl-N-[2-(1H-pyrazol-1-yl)ethyl]acetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 2.10 Å R-free 0.267
6PIQ Crystal Structure of EcDsbA in a complex with unpurified reaction product G6 (pyrazole 9) 提交 2019-06-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 2.10 Å R-free 0.267
6PLI Crystal Structure of EcDsbA in a complex with purified oxadiazole 11 提交 2019-07-01 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 ONY 2-[4-(4-cyano-3-methylphenoxy)phenyl]-N-methyl-N-[2-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.93 Å R-free 0.228
6PLI Crystal Structure of EcDsbA in a complex with purified oxadiazole 11 提交 2019-07-01 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.93 Å R-free 0.228
6PMF Crystal Structure of EcDsbA in complex with aniline 15 提交 2019-07-01 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 LD9 [6-(phenylamino)-1-benzofuran-3-yl]acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.95 Å R-free 0.227
6PMF Crystal Structure of EcDsbA in complex with aniline 15 提交 2019-07-01 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.95 Å R-free 0.227
6PML Crystal Structure of EcDsbA in complex benzyl ether 23 提交 2019-07-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 PEG DI(HYDROXYETHYL)ETHER × 1 OR4 [6-(benzyloxy)-1-benzofuran-3-yl]acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 2.00 Å R-free 0.221
6PML Crystal Structure of EcDsbA in complex benzyl ether 23 提交 2019-07-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 2.00 Å R-free 0.221
6POH Crystal Structure of EcDsbA in complex alkyl ether 21 提交 2019-07-03 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 OVG (6-butoxy-1-benzofuran-3-yl)acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.67 Å R-free 0.189
6POH Crystal Structure of EcDsbA in complex alkyl ether 21 提交 2019-07-03 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.67 Å R-free 0.189
6POI Crystal Structure of EcDsbA in complex phenyl ether 25 提交 2019-07-04 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 OVS (6-phenoxy-1-benzofuran-3-yl)acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.77 Å R-free 0.206
6POI Crystal Structure of EcDsbA in complex phenyl ether 25 提交 2019-07-04 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.77 Å R-free 0.206
6POQ Crystal Structure of EcDsbA in complex with anisidine 16 提交 2019-07-04 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 OVJ {6-[(4-methoxyphenyl)amino]-1-benzofuran-3-yl}acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.80 Å R-free 0.201
6POQ Crystal Structure of EcDsbA in complex with anisidine 16 提交 2019-07-04 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.80 Å R-free 0.201
6PVY E.coli DsbA in complex with benzofuran compound 26 ([6-(3-methoxyphenoxy)-1-benzofuran-3-yl]acetic acid) 提交 2019-07-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 OZG [6-(3-methoxyphenoxy)-1-benzofuran-3-yl]acetic acid × 1 DMS DIMETHYL SULFOXIDE × 1 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.74 Å R-free 0.225
6PVY E.coli DsbA in complex with benzofuran compound 26 ([6-(3-methoxyphenoxy)-1-benzofuran-3-yl]acetic acid) 提交 2019-07-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 DMS DIMETHYL SULFOXIDE × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.74 Å R-free 0.225
6PVZ E.coli DsbA in complex with benzofuran compound 28 ((6-benzyl-1-benzofuran-3-yl)acetic acid) 提交 2019-07-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 OZM (6-benzyl-1-benzofuran-3-yl)acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.200
6PVZ E.coli DsbA in complex with benzofuran compound 28 ((6-benzyl-1-benzofuran-3-yl)acetic acid) 提交 2019-07-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.200
6WHD Crystal structure of E.coli DsbA in complex with diaryl ether analogue 2 提交 2020-04-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 KFS [4-(4-cyano-3-methylphenoxy)phenyl]acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293 K;11-13% PEG8000, 5-7.5% glycerol, 1mM CuCl2, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.221
6WHD Crystal structure of E.coli DsbA in complex with diaryl ether analogue 2 提交 2020-04-08 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 KFS [4-(4-cyano-3-methylphenoxy)phenyl]acetic acid × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293 K;11-13% PEG8000, 5-7.5% glycerol, 1mM CuCl2, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.221
6XSP Crystal structure of E.coli DsbA in complex with 2-(2,6-bis(3-methoxyphenyl)benzofuran-3-yl)acetic acid 提交 2020-07-15 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 VCY [2,6-bis(3-methoxyphenyl)-1-benzofuran-3-yl]acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 2.30 Å R-free 0.246
6XSP Crystal structure of E.coli DsbA in complex with 2-(2,6-bis(3-methoxyphenyl)benzofuran-3-yl)acetic acid 提交 2020-07-15 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 2.30 Å R-free 0.246
6XSQ Crystal structure of E.coli DsbA in complex with 2-(6-(3-methoxyphenyl)-2-(4-methoxyphenyl)benzofuran-3-yl)acetic acid 提交 2020-07-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 VE7 [6-(3-methoxyphenyl)-2-(4-methoxyphenyl)-1-benzofuran-3-yl]acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 2.30 Å R-free 0.238
6XSQ Crystal structure of E.coli DsbA in complex with 2-(6-(3-methoxyphenyl)-2-(4-methoxyphenyl)benzofuran-3-yl)acetic acid 提交 2020-07-16 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 2.30 Å R-free 0.238
6XT3 Crystal structure of E.coli DsbA in complex with 3-(3-(carboxymethyl)-6-(3-methoxyphenyl)benzofuran-2-yl)benzoic acid 提交 2020-07-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 VED 3-[3-(carboxymethyl)-6-(3-methoxyphenyl)-1-benzofuran-2-yl]benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.232
6XT3 Crystal structure of E.coli DsbA in complex with 3-(3-(carboxymethyl)-6-(3-methoxyphenyl)benzofuran-2-yl)benzoic acid 提交 2020-07-17 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.232
7L76 Crystal Structure of EcDsbA in a complex with 2-(6-Phenylbenzofuran-3-yl)acetic acid 提交 2020-12-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 XPV (6-phenyl-1-benzofuran-3-yl)acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.83 Å R-free 0.224
7L76 Crystal Structure of EcDsbA in a complex with 2-(6-Phenylbenzofuran-3-yl)acetic acid 提交 2020-12-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.83 Å R-free 0.224
7L7C Crystal Structure of EcDsbA in a complex with 2-(6-(3-Methoxyphenyl)benzofuran-3-yl)acetic acid 提交 2020-12-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 XQ1 [6-(3-methoxyphenyl)-1-benzofuran-3-yl]acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.80 Å R-free 0.196
7L7C Crystal Structure of EcDsbA in a complex with 2-(6-(3-Methoxyphenyl)benzofuran-3-yl)acetic acid 提交 2020-12-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.80 Å R-free 0.196
7LHP Crystal Structure of EcDsbA in a complex with methyl 2-(6-bromo-2-phenylbenzofuran-3-yl)acetate 提交 2021-01-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 Y1G (6-bromo-2-phenyl-1-benzofuran-3-yl)acetic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.90 Å R-free 0.225
7LHP Crystal Structure of EcDsbA in a complex with methyl 2-(6-bromo-2-phenylbenzofuran-3-yl)acetate 提交 2021-01-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% glycerol, 100mM Na Cacodylate pH6.1, 1mM CuCl2
分辨率 1.90 Å R-free 0.225
7LSM Crystal structure of E.coli DsbA in complex with bile salt taurocholate 提交 2021-02-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 PEG DI(HYDROXYETHYL)ETHER × 1 TCH TAUROCHOLIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.79 Å R-free 0.207
7S1C Crystal structure of E.coli DsbA in complex with compound MIPS-0001897 (compound 1) 提交 2021-09-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 5VA ~{N}-methyl-1-(3-thiophen-3-ylphenyl)methanamine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.95 Å R-free 0.208
7S1C Crystal structure of E.coli DsbA in complex with compound MIPS-0001897 (compound 1) 提交 2021-09-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.95 Å R-free 0.208
7S1D Crystal structure of E.coli DsbA in complex with compound MIPS-0001877 (compound 39) 提交 2021-09-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 648 1-[3-(thiophen-3-yl)benzyl]piperidin-2-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.59 Å R-free 0.194
7S1D Crystal structure of E.coli DsbA in complex with compound MIPS-0001877 (compound 39) 提交 2021-09-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.59 Å R-free 0.194
7S1F Crystal structure of E.coli DsbA in complex with compound MIPS-0001886 (compound 38) 提交 2021-09-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 5VB 1-[(3-thiophen-3-ylphenyl)methyl]-3~{H}-pyrrol-2-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.76 Å R-free 0.201
7S1F Crystal structure of E.coli DsbA in complex with compound MIPS-0001886 (compound 38) 提交 2021-09-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.76 Å R-free 0.201
7S1L Crystal structure of E.coli DsbA in complex with compound MIPS-0001896 (compound 72) 提交 2021-09-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 62J methyl cis-4-({[3-(thiophen-3-yl)benzyl]amino}methyl)cyclohexanecarboxylate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.62 Å R-free 0.190
7S1L Crystal structure of E.coli DsbA in complex with compound MIPS-0001896 (compound 72) 提交 2021-09-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate
分辨率 1.62 Å R-free 0.190
7TTV E.coli DsbA in complex with 4-phenyl-2-(3-phenylpropyl)thiazole-5-carboxylic acid 提交 2022-02-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 QVP 4-phenyl-2-(3-phenylpropyl)-1,3-thiazole-5-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.227
7TTV E.coli DsbA in complex with 4-phenyl-2-(3-phenylpropyl)thiazole-5-carboxylic acid 提交 2022-02-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.99 Å R-free 0.227
8CXD Crystal Structure of EcDsbA in a complex with phenylmethanol 提交 2022-05-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 010 phenylmethanol × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.80 Å R-free 0.200
8CXD Crystal Structure of EcDsbA in a complex with phenylmethanol 提交 2022-05-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 010 phenylmethanol × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.80 Å R-free 0.200
8CXE Crystal Structure of EcDsbA in a complex with 1H-imidazole 提交 2022-05-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 IMD IMIDAZOLE × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.47 Å R-free 0.203
8CXE Crystal Structure of EcDsbA in a complex with 1H-imidazole 提交 2022-05-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 IMD IMIDAZOLE × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.47 Å R-free 0.203
8CZM Crystal Structure of EcDsbA in a complex with 4-bromo-1H-pyrazole 提交 2022-05-25 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 BYZ 4-bromo-1H-pyrazole × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.80 Å R-free 0.221
8CZM Crystal Structure of EcDsbA in a complex with 4-bromo-1H-pyrazole 提交 2022-05-25 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 BYZ 4-bromo-1H-pyrazole × 2 PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.80 Å R-free 0.221
8CZN Crystal Structure of EcDsbA in a complex with 1H-pyrrole-3-carboxylic acid 提交 2022-05-25 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 PKN 1H-pyrrole-3-carboxylic acid × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.70 Å R-free 0.215
8CZN Crystal Structure of EcDsbA in a complex with 1H-pyrrole-3-carboxylic acid 提交 2022-05-25 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 PKN 1H-pyrrole-3-carboxylic acid × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.70 Å R-free 0.215
8D10 Crystal Structure of EcDsbA in a complex with (1-methyl-1H-pyrazol-5-yl)methanamine 提交 2022-05-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 Q2I 1-(1-methyl-1H-pyrazol-5-yl)methanamine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.60 Å R-free 0.198
8D10 Crystal Structure of EcDsbA in a complex with (1-methyl-1H-pyrazol-5-yl)methanamine 提交 2022-05-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 Q2I 1-(1-methyl-1H-pyrazol-5-yl)methanamine × 2 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.60 Å R-free 0.198
8D11 Crystal Structure of EcDsbA in a complex with 1-methyl-1H-pyrazol-5-amine 提交 2022-05-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 Q2O 1-methyl-1H-pyrazol-5-amine × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.85 Å R-free 0.220
8D11 Crystal Structure of EcDsbA in a complex with 1-methyl-1H-pyrazol-5-amine 提交 2022-05-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 Q2O 1-methyl-1H-pyrazol-5-amine × 3 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.85 Å R-free 0.220
8D12 Crystal Structure of EcDsbA in a complex with 1-methyl-1H-pyrazol-4-amine 提交 2022-05-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 Q3F 1-methyl-1H-pyrazol-4-amine × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.60 Å R-free 0.200
8D12 Crystal Structure of EcDsbA in a complex with 1-methyl-1H-pyrazol-4-amine 提交 2022-05-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 Q3F 1-methyl-1H-pyrazol-4-amine × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.60 Å R-free 0.200
8DG0 Crystal Structure of EcDsbA in a complex with Urea 提交 2022-06-23 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 URE UREA × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 2.50 Å R-free 0.257
8DG0 Crystal Structure of EcDsbA in a complex with Urea 提交 2022-06-23 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 URE UREA × 1 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 2.50 Å R-free 0.257
8DG1 Crystal Structure of EcDsbA in a complex with DMSO 提交 2022-06-23 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 DMS DIMETHYL SULFOXIDE × 11 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.95 Å R-free 0.221
8DG1 Crystal Structure of EcDsbA in a complex with DMSO 提交 2022-06-23 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 DMS DIMETHYL SULFOXIDE × 9 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.95 Å R-free 0.221
8DG2 Crystal Structure of EcDsbA in a complex with DMSO 提交 2022-06-23 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 GOL GLYCEROL × 1 DMS DIMETHYL SULFOXIDE × 7 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.95 Å R-free 0.222
8DG2 Crystal Structure of EcDsbA in a complex with DMSO 提交 2022-06-23 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 DMS DIMETHYL SULFOXIDE × 7 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.1;293.15 K;11-13 % PEG 8000, 5-7.5% GLYCEROL, 100MM NA CACODYLATE PH6.1, 1MM CuCl2
分辨率 1.95 Å R-free 0.222
8DN0 E.coli DsbA in complex with N-(2-fluorophenyl)-5-methylisoxazole-3-carboxamide 提交 2022-07-10 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 SW0 N-(2-fluorophenyl)-5-methyl-1,2-oxazole-3-carboxamide × 1 EDO 1,2-ETHANEDIOL × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.57 Å R-free 0.194
8DN0 E.coli DsbA in complex with N-(2-fluorophenyl)-5-methylisoxazole-3-carboxamide 提交 2022-07-10 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 SW0 N-(2-fluorophenyl)-5-methyl-1,2-oxazole-3-carboxamide × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.57 Å R-free 0.194
8EOC Crystal structure of E.coli DsbA mutant E24A/K58A 提交 2022-10-03 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
突变:E24A, K58A GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.47 Å R-free 0.197
8EOC Crystal structure of E.coli DsbA mutant E24A/K58A 提交 2022-10-03 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
突变:E24A, K58A GOL GLYCEROL × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.47 Å R-free 0.197
8EQO Crystal structure of E.coli DsbA mutant K58A 提交 2022-10-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
突变:K58A GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.62 Å R-free 0.184
8EQO Crystal structure of E.coli DsbA mutant K58A 提交 2022-10-08 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
突变:K58A GOL GLYCEROL × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.62 Å R-free 0.184
8EQP Crystal structure of E.coli DsbA mutant E24A/E37A/K58A 提交 2022-10-09 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
突变:E24A, E37A, K58A GOL GLYCEROL × 1 FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.30 Å R-free 0.253
8EQP Crystal structure of E.coli DsbA mutant E24A/E37A/K58A 提交 2022-10-09 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
突变:E24A, E37A, K58A GOL GLYCEROL × 1 FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.30 Å R-free 0.253
8EQP Crystal structure of E.coli DsbA mutant E24A/E37A/K58A 提交 2022-10-09 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 20–208(189 aa)
突变:E24A, E37A, K58A GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.30 Å R-free 0.253
8EQP Crystal structure of E.coli DsbA mutant E24A/E37A/K58A 提交 2022-10-09 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 20–208(189 aa)
突变:E24A, E37A, K58A GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.30 Å R-free 0.253
8EQQ Crystal structure of E.coli DsbA mutant E37A 提交 2022-10-09 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
突变:E37A FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.13 Å R-free 0.231
8EQQ Crystal structure of E.coli DsbA mutant E37A 提交 2022-10-09 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
突变:E37A FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.13 Å R-free 0.231
8EQQ Crystal structure of E.coli DsbA mutant E37A 提交 2022-10-09 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 20–208(189 aa)
突变:E37A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.13 Å R-free 0.231
8EQQ Crystal structure of E.coli DsbA mutant E37A 提交 2022-10-09 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 20–208(189 aa)
突变:E37A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.13 Å R-free 0.231
8EQR Crystal structure of E.coli DsbA mutant E24A 提交 2022-10-09 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
突变:E24A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.29 Å R-free 0.259
8EQR Crystal structure of E.coli DsbA mutant E24A 提交 2022-10-09 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
突变:E24A PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.29 Å R-free 0.259
8EQR Crystal structure of E.coli DsbA mutant E24A 提交 2022-10-09 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 20–208(189 aa)
突变:E24A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.29 Å R-free 0.259
8EQR Crystal structure of E.coli DsbA mutant E24A 提交 2022-10-09 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 20–208(189 aa)
突变:E24A PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;15-20% PEG8000, 0.1M phosphate-citrate, pH 3.8-4.4, 0.2M NaCl
分辨率 2.29 Å R-free 0.259
8U1Y E.coli DsbA in complex with N-(4-(thiophen-3-yl)benzyl)cyclohexanamine 提交 2023-09-04 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 5V9 ~{N}-[(4-thiophen-3-ylphenyl)methyl]cyclohexanamine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.74 Å R-free 0.202
8U1Y E.coli DsbA in complex with N-(4-(thiophen-3-yl)benzyl)cyclohexanamine 提交 2023-09-04 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.74 Å R-free 0.202
8U59 EcDsbA soaked with N-(2-fluorophenyl)-5-methylisoxazole-3-carboxamide and N-(4-(thiophen-3-yl)benzyl)cyclohexanamine 提交 2023-09-12 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 5V9 ~{N}-[(4-thiophen-3-ylphenyl)methyl]cyclohexanamine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.77 Å R-free 0.222
8U59 EcDsbA soaked with N-(2-fluorophenyl)-5-methylisoxazole-3-carboxamide and N-(4-(thiophen-3-yl)benzyl)cyclohexanamine 提交 2023-09-12 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 SW0 N-(2-fluorophenyl)-5-methyl-1,2-oxazole-3-carboxamide × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.77 Å R-free 0.222
8UBQ EcDsbA soaked with N-(2-fluorophenyl)-5-methylisoxazole-3-carboxamide and 2-benzyl-4-phenylthiazole-5-carboxylic acid 提交 2023-09-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 W9H 2-benzyl-4-phenyl-1,3-thiazole-5-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 2.00 Å R-free 0.223
8UBQ EcDsbA soaked with N-(2-fluorophenyl)-5-methylisoxazole-3-carboxamide and 2-benzyl-4-phenylthiazole-5-carboxylic acid 提交 2023-09-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 SW0 N-(2-fluorophenyl)-5-methyl-1,2-oxazole-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 2.00 Å R-free 0.223
8UF9 EcDsbA in complex with 2-benzyl-4-phenylthiazole-5-carboxylic acid 提交 2023-10-04 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 W9H 2-benzyl-4-phenyl-1,3-thiazole-5-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 2.16 Å R-free 0.234
8UF9 EcDsbA in complex with 2-benzyl-4-phenylthiazole-5-carboxylic acid 提交 2023-10-04 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 2.16 Å R-free 0.234
9NHG E.coli DsbA in complex with N-(2-aminophenyl)-5-methylisoxazole-3-carboxamide 提交 2025-02-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 20–208(189 aa)
链 B 20–208(189 aa)
未记录 A1BX8 N-(2-aminophenyl)-5-methyl-1,2-oxazole-3-carboxamide × 2 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 2.04 Å R-free 0.221
9NIC E.coli DsbA in complex with N-(2-amino-3-fluorophenyl)-5-methylisoxazole-3-carboxamide 提交 2025-02-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
未记录 A1BYA N-(2-amino-3-fluorophenyl)-5-methyl-1,2-oxazole-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.96 Å R-free 0.236
9NIC E.coli DsbA in complex with N-(2-amino-3-fluorophenyl)-5-methylisoxazole-3-carboxamide 提交 2025-02-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
未记录 A1BYA N-(2-amino-3-fluorophenyl)-5-methyl-1,2-oxazole-3-carboxamide × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM copper(II) chloride, 100 mM sodium cacodylate
分辨率 1.96 Å R-free 0.236
9PRE Crystal structure of oxidised E.coli DsbA in complex with propiolic acid 提交 2025-07-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–207(188 aa)
未记录 ZN ZINC ION × 2 A1CJH 3-{3-[(5-methyl-1,2-oxazole-3-carbonyl)amino]phenyl}prop-2-ynoic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate pH 6.1
分辨率 1.68 Å R-free 0.182
9PRF Crystal structure of E.coli DsbA in-complex with analogue 6 提交 2025-07-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–207(188 aa)
未记录 A1CQW N-[3-(3-{[(2S)-2-hydroxybutyl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate pH 6.1
分辨率 1.61 Å R-free 0.215
9PRF Crystal structure of E.coli DsbA in-complex with analogue 6 提交 2025-07-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–207(188 aa)
未记录 A1CQW N-[3-(3-{[(2S)-2-hydroxybutyl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide × 1 A1CJJ N-[3-(3-{[(2R)-2-hydroxybutyl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate pH 6.1
分辨率 1.61 Å R-free 0.215
9PRG Crystal structure of E.coli DsbA in-complex with analogue 7 提交 2025-07-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–207(188 aa)
未记录 LYS LYSINE × 1 A1CJK N-[3-(3-{[(1S)-2-hydroxy-1-phenylethyl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate pH 6.1
分辨率 1.65 Å R-free 0.218
9PRG Crystal structure of E.coli DsbA in-complex with analogue 7 提交 2025-07-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–207(188 aa)
未记录 LYS LYSINE × 1 A1CJK N-[3-(3-{[(1S)-2-hydroxy-1-phenylethyl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate pH 6.1
分辨率 1.65 Å R-free 0.218
9PRH Crystal structure of E.coli DsbA in-complex with analogue 8 提交 2025-07-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–207(188 aa)
未记录 A1CJL N-[3-(3-{[(2R)-2,3-dihydroxypropyl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate pH 6.1
分辨率 2.08 Å R-free 0.252
9PRI Crystal structure of oxidised E.coli DsbA in-complex with analogue 9 提交 2025-07-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–207(188 aa)
未记录 A1CJM N-[3-(3-{[(2S)-1-hydroxy-3-(1H-imidazol-4-yl)propan-2-yl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide × 1 1PE PENTAETHYLENE GLYCOL × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate pH 6.1
分辨率 1.27 Å R-free 0.194
9PRJ Crystal structure of E.coli DsbA in-complex with analogue 13 提交 2025-07-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–207(188 aa)
未记录 A1CJN N-[3-(3-{[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide × 1 PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;11-13% PEG 8000, 5-7.5% glycerol, 1 mM CuCl2, 100 mM sodium cacodylate pH 6.1
分辨率 1.81 Å R-free 0.233
9PRK Crystal structure of E.coli DsbA in complex with analogue 17 提交 2025-07-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–207(188 aa)
未记录 A1CJO methyl {2,6-difluoro-4-[(2S)-3-hydroxy-2-(3-{3-[(5-methyl-1,2-oxazole-3-carbonyl)amino]phenyl}prop-2-ynamido)propyl]phenyl}acetate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 3000, TRIS, sodium chloride
分辨率 1.76 Å R-free 0.235
9PRK Crystal structure of E.coli DsbA in complex with analogue 17 提交 2025-07-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–207(188 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 3000, TRIS, sodium chloride
分辨率 1.76 Å R-free 0.235
9PRL Crystal structure of E.coli DsbA in complex with analogue 18 提交 2025-07-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 21–207(187 aa)
未记录 A1CJP methyl {2-chloro-4-[(2S)-3-hydroxy-2-(3-{3-[(5-methyl-1,2-oxazole-3-carbonyl)amino]phenyl}prop-2-ynamido)propyl]phenyl}acetate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;Sodium phosphate, Potassium phosphate, Sodium acetate pH 4.5
分辨率 1.91 Å R-free 0.225
9PRL Crystal structure of E.coli DsbA in complex with analogue 18 提交 2025-07-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 21–207(187 aa)
未记录 A1CJP methyl {2-chloro-4-[(2S)-3-hydroxy-2-(3-{3-[(5-methyl-1,2-oxazole-3-carbonyl)amino]phenyl}prop-2-ynamido)propyl]phenyl}acetate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;Sodium phosphate, Potassium phosphate, Sodium acetate pH 4.5
分辨率 1.91 Å R-free 0.225
9PRM Crystal structure of E.coli DsbA in complex with analogue 20 提交 2025-07-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 21–207(187 aa)
未记录 A1CJQ N-{3-[3-({(2S)-1-[4-(benzyloxy)-3-fluorophenyl]-3-hydroxypropan-2-yl}amino)-3-oxoprop-1-yn-1-yl]phenyl}-5-methyl-1,2-oxazole-3-carboxamide × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;PEG 3000, sodium chloride, TRIS
分辨率 2.10 Å R-free 0.221
9PRM Crystal structure of E.coli DsbA in complex with analogue 20 提交 2025-07-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 21–207(187 aa)
未记录 A1CJQ N-{3-[3-({(2S)-1-[4-(benzyloxy)-3-fluorophenyl]-3-hydroxypropan-2-yl}amino)-3-oxoprop-1-yn-1-yl]phenyl}-5-methyl-1,2-oxazole-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;PEG 3000, sodium chloride, TRIS
分辨率 2.10 Å R-free 0.221
9Y0M Crystal structure of Escherichia coli DsbA P151T mutant 提交 2025-08-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
突变:P151T PEG DI(HYDROXYETHYL)ETHER × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;1 M Ammonium sulphate 25% PEG 8000
分辨率 2.88 Å R-free 0.268
9Y0M Crystal structure of Escherichia coli DsbA P151T mutant 提交 2025-08-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
突变:P151T GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;1 M Ammonium sulphate 25% PEG 8000
分辨率 2.88 Å R-free 0.268
9Y0M Crystal structure of Escherichia coli DsbA P151T mutant 提交 2025-08-28 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 20–208(189 aa)
突变:P151T PEG DI(HYDROXYETHYL)ETHER × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;1 M Ammonium sulphate 25% PEG 8000
分辨率 2.88 Å R-free 0.268
9Y0M Crystal structure of Escherichia coli DsbA P151T mutant 提交 2025-08-28 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 20–208(189 aa)
突变:P151T GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;1 M Ammonium sulphate 25% PEG 8000
分辨率 2.88 Å R-free 0.268
9Y0N Crystal structure of Escherichia coli DsbA G149K mutant 提交 2025-08-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
突变:G149K GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.6;293 K;0.1 M Sodium acetate trihydrate pH 4.6, 2.0M sodium chloride
分辨率 2.00 Å R-free 0.243
9Y0N Crystal structure of Escherichia coli DsbA G149K mutant 提交 2025-08-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
突变:G149K GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.6;293 K;0.1 M Sodium acetate trihydrate pH 4.6, 2.0M sodium chloride
分辨率 2.00 Å R-free 0.243
9Y0O Crystal structure of Escherichia coli DsbA G149T mutant 提交 2025-08-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–208(189 aa)
突变:G149T GOL GLYCEROL × 9 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M Ammonium sulphate, 30% w/v Polyethylene glycol 4,000
分辨率 1.79 Å R-free 0.225
9Y0O Crystal structure of Escherichia coli DsbA G149T mutant 提交 2025-08-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 20–208(189 aa)
突变:G149T GOL GLYCEROL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M Ammonium sulphate, 30% w/v Polyethylene glycol 4,000
分辨率 1.79 Å R-free 0.225
9Y0P Crystal structure of Escherichia coli DsbA C33A mutant in complex with a peptide derived from LptD - Binding mode I 提交 2025-08-28 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 20–208(189 aa)
突变:C33A GOL GLYCEROL × 1 NO3 NITRATE ION × 3 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M Calcium acetate hydrate, 20% w/v Polyethylene glycol 3,350
分辨率 1.47 Å R-free 0.210
9Y0P Crystal structure of Escherichia coli DsbA C33A mutant in complex with a peptide derived from LptD - Binding mode I 提交 2025-08-28 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 20–208(189 aa)
突变:C33A GOL GLYCEROL × 1 NO3 NITRATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M Calcium acetate hydrate, 20% w/v Polyethylene glycol 3,350
分辨率 1.47 Å R-free 0.210
9Y0Q Crystal structure of Escherichia coli DsbA C33A mutant in complex with a peptide derived from LptD - Binding mode II 提交 2025-08-28 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 20–208(189 aa)
突变:C33A GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M Magnesium nitrate hexahydrate, 20% w/v Polyethylene glycol 3,350
分辨率 1.47 Å R-free 0.213